recent articles

Join us for our May 13 webinar on How to Develop Fit-for-Purpose Quantitative IHC Assays to Enable Clinical Trial Patient Stratification. Dr. Sharon Moulis will be presenting how traditional methods of IHC assay design can be modified with...

WEBINAR ANNOUNCEMENT ONCOLOGY WEBINAR SERIES Quantification of IHC and ISH cancer biomarkers using HALO PRESENTER: KATE LILLARD, PHD | INDICA LABS Indica Labs offers dedicated analysis tools for cancer research using...

Enzo Biochem and Flagship Biosciences partner to provide tissue-based companion diagnostics offering complete solution for in situ hybridization development to pharmaceutical companies New York, NY – December 11, 2013 - Enzo Biochem Inc....

Dako and Omnyx recently announced a collaborative effort to combine Dako's stains with Omnyx's digital pathology platform for use in Europe.  This speaks to one of the two major value propositions for digital pathology (in my opinion) - image...

The following post was submitted by Dr. Holger Lange, CTO of Flagship Biosciences, who is working with a number of pharmaceutical partners on regulatory companion diagnostics development. Digital Pathology is a new technology, a new industry,...

Legal disclaimer: This post has nothing to do with digital pathology. It is just a personal battle between a man, new technology, a steep driveway, and a lot of snow. It has nothing to do with digital pathology. I live on a steep driveway in...

OR

platinum partners

gold partners

Silver Partners

Media Partners